10.15131/shef.data.11956143.v1
Jean Sanderson
Jean
Sanderson
Marrissa Martyn-St James
Marrissa
Martyn-St James
Sarah Davies
Sarah
Davies
John Stevens
John
Stevens
Edward Goka
Edward
Goka
Susie Sadler
Susie
Sadler
Clinical effectiveness of bisphosphonates for prevention of fragility fractures: a systematic review and network meta-analysis
The University of Sheffield
2020
Clinical effectiveness
bisphosphonates
fragility fractures
systematic review
network meta-analysis
NIHR
osteoporosis
NMA
alendronate
risedronate
Ibandronate
zoledronate
Health Economics
2020-03-09 16:20:37
Poster
https://orda.shef.ac.uk/articles/poster/Clinical_effectiveness_of_bisphosphonates_for_prevention_of_fragility_fractures_a_systematic_review_and_network_meta-analysis/11956143
BACKGROUND
Osteoporosis is characterised by low bone mass and structural
deterioration of bone tissue, with a consequent increase in
susceptibility to fragility fracture. Fractures cause significant pain,
disability and loss of independence and can be fatal.
[1]
OBJECTIVE
To assess the relative efficacy of bisphosphonates (alendronate,
risedronate, ibandronate and zoledronate) for the treatment of
Osteoporosis using a network meta-analysis (NMA).